115 related articles for article (PubMed ID: 24897087)
1. Clinical problem-solving. Spot diagnosis.
Stark Z; Campbell LJ; Mitchell C; James PA; Heath JA; Boussioutas A; Lynch C; Trainer AH
N Engl J Med; 2014 Jun; 370(23):2229-36. PubMed ID: 24897087
[No Abstract] [Full Text] [Related]
2. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Hicks SC; Ward RL; Hawkins NJ
Pathology; 2011 Jan; 43(1):84-5; author reply 85-6. PubMed ID: 21240077
[No Abstract] [Full Text] [Related]
4. Germline PMS2 mutations: one hit or two?
Gryfe R; Gallinger S
Gastroenterology; 2005 May; 128(5):1506-9. PubMed ID: 15887130
[No Abstract] [Full Text] [Related]
5. Clearer picture of PMS2-associated lynch syndrome is emerging.
Daniels MS; Lu KH
J Clin Oncol; 2015 Feb; 33(4):299-300. PubMed ID: 25534383
[No Abstract] [Full Text] [Related]
6. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
7. PMS2 mutations in HNPCC.
Hayward BE; De Vos M; Sheridan E; Bonthron DT
Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
[No Abstract] [Full Text] [Related]
8. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
[No Abstract] [Full Text] [Related]
9. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
[TBL] [Abstract][Full Text] [Related]
10. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
[TBL] [Abstract][Full Text] [Related]
11. Biallelic PMS2 mutations and a distinctive childhood cancer syndrome.
Tan TY; Orme LM; Lynch E; Croxford MA; Dow C; Dewan PA; Lipton L
J Pediatr Hematol Oncol; 2008 Mar; 30(3):254-7. PubMed ID: 18376293
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
Ponti G; Ruini C; Tomasi A
Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
[No Abstract] [Full Text] [Related]
13. Anticipating phenotypic differences from genetic mutations.
You YN
Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706
[No Abstract] [Full Text] [Related]
14. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
[TBL] [Abstract][Full Text] [Related]
15. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
de Vos M; Hayward B; Bonthron DT; Sheridan E
Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
[TBL] [Abstract][Full Text] [Related]
16. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
[TBL] [Abstract][Full Text] [Related]
17. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
[No Abstract] [Full Text] [Related]
18. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic rhabdomyosarcoma in a patient with hereditary nonpolyposis colorectal cancer.
Cranmer LD; Chen CC; Morgan S; Martino G; Ray J
J Clin Oncol; 2013 Mar; 31(7):e108-10. PubMed ID: 23319697
[No Abstract] [Full Text] [Related]
20. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
